Visualize how your peptide clears from the body — half-life, steady state, and accumulation for every injection schedule.
Half-Life
~30 min
Time for 50 % to be eliminated
Steady State
~2 h
≈ 4.3 half-lives
Accumulation
×1.00
Cmax at steady state ÷ Cmax first dose
Gone After
~4 h
after last dose
Source: Literature estimate. Research tool. Uses a simplified first-order elimination model and normalizes concentration to % of peak. Not a medical or dosing recommendation. Tesamorelin: ~30 min.
Tesamorelin has a reported half-life of about 30 minutes. Under a daily dosing schedule, the peptide clears entirely within a few hours. Steady state is reached at roughly 4.3 half-lives, about 2 hours, and there is no meaningful accumulation between daily doses.
The blue line plots concentration as a percentage of the first-dose peak. The dashed reference line marks the steady-state peak. After the last dose, concentration drops below 1 % of the peak after about 3.5 hours, seven half-lives.
Tesamorelin is an FDA-approved GHRH analogue that stimulates endogenous growth hormone release. It is studied at daily doses of 1 to 2 mg via subcutaneous injection. The very short half-life means each dose produces a brief GH pulse followed by complete clearance, mimicking the natural pulsatile pattern of GH secretion.